Microbot Medical Inc. Leases Disclosure
NOTE 7 - LEASES
In March 2025, the Company entered into a lease agreement for its US office for the period from March 2025 until February 2027. The monthly lease payments are approximately $2.
In July 2025, the Subsidiary entered into a lease agreement for its Israel office for the period from July 2025 until October 2029. The monthly lease payments are approximately $20. To secure the lease payments, the Company issued a bank guarantee of $56 in favor of the facility’s lessor.
Additionally, the Company has several agreements for car leases.
For the years ended December 31, 2025 and 2024, operating lease cost, which is classified as a component of research and development in the consolidated statement of comprehensive loss for all periods presented, was $256 and $215, respectively. Also for the years ended December 31, 2025 and 2024, cash paid under operating lease agreements were $212 and $219, respectively.
Undiscounted maturities of future operating lease payments as of December 31, 2025 are summarized as follows:
| As of December 31, | ||||
| 2025 | ||||
| 2026 | $ | 308 | ||
| 2027 | 256 | |||
| 2028 | 238 | |||
| 2029 | 196 | |||
| Total future lease payments | 998 | |||
| Less imputed interest | (133 | ) | ||
| Total lease liabilities | $ | 865 | ||
The following table includes the weighted-average lease terms and discount rates for operating leases as of December 31, 2025 and 2024:
| As of December 31, | ||||||||
| 2025 | 2024 | |||||||
| Operating leases weighted-average remaining lease term (in years) | 3.6 | 1.6 | ||||||
| Operating leases weighted-average discount rate | 8.2 | % | 6.7 | % | ||||
MICROBOT MEDICAL INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands
(Except share and per share data)
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 26, 2026 | Showing above |
| 2024 | Mar 25, 2025 | |
| 2023 | Mar 27, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Mar 31, 2022 | |
| 2020 | Mar 31, 2021 | |
| 2019 | Apr 14, 2020 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.